We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
- Authors
Ramalingam, Suresh S; Dahlberg, Suzanne E; Langer, Corey J; Gray, Robert; Belani, Chandra P; Brahmer, Julie R; Sandler, Alan B; Schiller, Joan H; Johnson, David H; Eastern Cooperative Oncology Group
- Abstract
Fit elderly patients with advanced non-small-cell lung cancer (NSCLC) benefit from platinum-based, two-drug chemotherapy. Bevacizumab (B) in combination with carboplatin (C) and paclitaxel (P) improves survival for advanced, nonsquamous NSCLC, as evidenced in Eastern Cooperative Oncology Group (ECOG) 4599. We conducted a subset analysis of ECOG 4599 to determine the outcome for elderly patients.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 1, p60
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.13.1144